+Vote!
PR News Wire (Free subscription) | 06/01/2009
DEERFIELD, Ill., Jan. 6 /PRNewswire-FirstCall/ -- Baxter International (NYSE: ), will host a quarterly conference call to discuss its fourth quarter 2008 financial results on Thursday, January 22, 2009, at 8:30 a.m. Eastern Time (7:30 a.m. Central Time). To access the call, please dial 866-238-0637 (domestic) or 703-639-1156 (international). Please dial into the call at least ten minutes prior...
+Vote!
Signs of the Times (Free subscription) | yesterday
Baxter International Inc. and other drug companies sold blood-clotting medicine for hemophiliacs that carried a high risk of transmitting AIDS to markets in Europe more than a year after switching to newer, safer products in the United States, according to a lawsuit filed here Friday. The suit names as plaintiffs several dozen people in Italy and the United Kingdom who claim they, or...
+Vote!
Medical News Today (Free subscription) | 06/01/2009
Baxter International Inc. and Halozyme Therapeutics, Inc. (Nasdaq: HALO) announced the start of a Phase III clinical trial of Baxter's GAMMAGARD LIQUID [Immune Globulin Intravenous] 10% (IGIV), marketed as KIOVIG in the European Union, with Halozyme's recombinant human hyaluronidase enzyme (rHuPH20, Enhanze(TM) Technology) for the treatment of primary immunodeficiency (PID).
+Vote!
Business Wire (Free subscription) | 05/01/2009
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE: BAX) announced today that it will present at the 27th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2009 at 11:00 a.m. (PST) or
+Vote!
Financial24 (Free subscription) | 31/12/2008
1. Heparin: Deerfield-based medical products-maker Baxter International Inc. came under fire and concerns about the safety of its Chinese supply chain were raised after a tainted blood thinner called
+Vote!
Daily Advance - Business (Free subscription) | 31/12/2008
... more discretionary parts of the economy, like automobiles. But Boston Scientific Corp., Medtronic Inc. and other device makers performed far worse than their peers in the biotech industry.Some parts of the sector took a hit from tightening consumer spending on non-essentials. Cosmetic treatment company Allergan Inc. slashed its outlook in October on plummeting demand for its breast...
+Vote!
Miami Herald (Free subscription) | 31/12/2008
... more discretionary parts of the economy, like automobiles. But Boston Scientific Corp., Medtronic Inc. and other device makers performed far worse than their peers in the biotech industry.Some parts of the sector took a hit from tightening consumer spending on non-essentials. Cosmetic treatment company Allergan Inc. slashed its outlook in October on plummeting demand for its breast...
+Vote!
Seattle Post-Intelligencer (Free subscription) | 31/12/2008
... more discretionary parts of the economy, like automobiles. But Boston Scientific Corp., Medtronic Inc. and other device makers performed far worse than their peers in the biotech industry.Some parts of the sector took a hit from tightening consumer spending on non-essentials. Cosmetic treatment company Allergan Inc. slashed its outlook in October on plummeting demand for its breast...
+Vote!
Seattle Times (Free subscription) | 31/12/2008
... more discretionary parts of the economy, like automobiles. But Boston Scientific Corp., Medtronic Inc. and other device makers performed far worse than their peers in the biotech industry.Some parts of the sector took a hit from tightening consumer spending on non-essentials. Cosmetic treatment company Allergan Inc. slashed its outlook in October on plummeting demand for its breast...
